<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1363018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The association between primary frozen shoulder and serum lipids may be overestimated: evidence based on retrospective observational studies and Mendelian randomization</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yongchao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Wenhao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yichang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2012916"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Tengjing</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Deding</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shao</surname>
<given-names>Yiming</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1785124"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Joint and Sports Injuries, Zhengzhou Central Hospital Affiliated to Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Foot and Ankle Surgery, Zhengzhou Orthopedic Hospital Affiliated to Henan University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pain, Shunde Hospital of Southern Medical University</institution>, <addr-line>Foshan</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Orthopedics, The Second Affiliated Hospital of Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Trauma Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Xiaonan Liu, Johns Hopkins Medicine, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Mohsen Norouzinia, Shahid Beheshti University of Medical Sciences, Iran</p>
<p>Yiyong Zhao, Harvard University, United States</p>
<p>Mengmeng Zhai, Alliance Pharma, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Yiming Shao, <email xlink:href="mailto:yiming9710@163.com">yiming9710@163.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1363018</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Zhang, Fan, Wang, Dong, Liu and Shao</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zhang, Fan, Wang, Dong, Liu and Shao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Previous studies have shown that dyslipidemia is significantly associated with primary frozen shoulder and may be a risk factor for the development of primary frozen shoulder. However, these findings may be biased by a number of confounding factors. We investigated the association between serum lipids and primary frozen shoulder by retrospective analysis and two-sample Mendelian randomization (MR) methods.</p>
</sec>
<sec>
<title>Methods</title>
<p>This retrospective observational study included 284 patients with primary frozen shoulder diagnosed from October 2020 to October 2023 at four centers as the experimental group. Patients with diabetes and thyroid dysfunction were excluded. The control group consisted of age- and sex-matched people who underwent a health checkup. We compared total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) between the two groups. Genetic variants for the serum lipids and frozen shoulder were then extracted from large-scale genome-wide association studies. Causal effects were assessed using Inverse variance weighting (IVW), Weighted median, MR-Egger, simple and weighted models in MR analysis.</p>
</sec>
<sec>
<title>Results</title>
<p>The analysis showed that after excluding patients with diabetes and thyroid dysfunction, the serum lipids (TC, TG, HDL, and LDL) in the primary frozen shoulder group were no different from those of normal individuals. None of the MR methods found significant causal evidence between them.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Dyslipidemia in patients with primary frozen shoulder may be influenced by confounding factors such as diabetes and thyroid dysfunction. These findings deepen our understanding of primary frozen shoulder risk factors.</p>
</sec>
</abstract>
<kwd-group>
<kwd>primary frozen shoulder</kwd>
<kwd>serum lipid</kwd>
<kwd>Mendelian randomization</kwd>
<kwd>correlation</kwd>
<kwd>causality</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="29"/>
<page-count count="11"/>
<word-count count="4005"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Bone Research</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>For Primary frozen shoulder, also known as &#x201c;adhesive capsulitis of the shoulder&#x201d;, is a common shoulder disorder characterized by spontaneous pain and limited shoulder motion (<xref ref-type="bibr" rid="B1">1</xref>). The major risk factors for primary frozen shoulder that have been reported include age, female gender, diabetes mellitus, and thyroid diseases (<xref ref-type="bibr" rid="B2">2</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>). Because the mechanisms of primary frozen shoulder development are unknown, identifying possible risk factors is particularly important for the diagnosis and clinical management of primary frozen shoulder.</p>
<p>Bunker&#x2019;s study (<xref ref-type="bibr" rid="B5">5</xref>) provided the first indication that dyslipidemia may be a risk factor for the pathogenesis of frozen shoulder. This was based on the finding that the pathologic manifestations of frozen shoulder are very similar to Dupuytren&#x2019;s disease, which is known to be associated with hyperlipidemia. Subsequently Bunker et&#xa0;al. (<xref ref-type="bibr" rid="B6">6</xref>) further found that fasting serum triglyceride (TG) and cholesterol levels were significantly higher in patients with frozen shoulder than in healthy controls. However, the significance of this study is limited by the fact that the effects of confounding factors (such as diabetes mellitus and thyroid dysfunction) were not considered. Dyslipidemia is frequent in patients with diabetes mellitus and thyroid disease, and it is not possible to identify dyslipidemia as an independent risk factor for primary frozen shoulder (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). With this in mind, Sung et&#xa0;al. (<xref ref-type="bibr" rid="B9">9</xref>) conducted a case-control study after excluding patients with diabetes mellitus and thyroid dysfunction. Although the results had significance in continuous and categorical values, the actual differences between the two study groups of these serum lipid levels were small. The relationship between primary frozen shoulder and dyslipidemia remains ambiguous, therefore strong evidence of a correlation is needed. And to the best of our knowledge, there has not been a study exploring the causal relationship between primary frozen shoulder and dyslipidemia.</p>
<p>In this study, we performed a multicenter retrospective analysis to assess the correlation between total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), TG, and primary frozen shoulder. The patients with already diagnosed diabetes mellitus and thyroid dysfunction were excluded. We then used two-sample Mendelian randomization (MR) to assess the causal relationship between primary frozen shoulder and dyslipidemia. This method avoids interference from reverse causal associations and potential confounders encountered in conventional randomized controlled trials by using the random distribution of genetic variation and simulating the randomization process of a randomized controlled experiment (<xref ref-type="bibr" rid="B10">10</xref>).</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Clinical study design</title>
<p>This retrospective observational study included patients with primary frozen shoulder diagnosed from October 2020 to October 2023 at four centers as the experimental group. The control group consisted of age- and sex-matched people who underwent a health checkup. The inclusion criteria were as follows:(a) Patients in the experimental group met the diagnostic criteria for primary frozen shoulder (<xref ref-type="bibr" rid="B11">11</xref>), including painful freezing phase, adhesive phase, and resolution phase; (b) The control population showed normal shoulder motion and no shoulder symptoms. The exclusion criteria were as follows: (a) Patients diagnosed with type 1 diabetes (<xref ref-type="bibr" rid="B12">12</xref>) and type 2 diabetes (<xref ref-type="bibr" rid="B13">13</xref>); (b) Patients diagnosed with hyperthyroidism (<xref ref-type="bibr" rid="B14">14</xref>) and hypothyroidism (<xref ref-type="bibr" rid="B15">15</xref>); (c) Patients with previous shoulder surgery or trauma.</p>
<p>The clinical data of all enrolled patients were collected, including gender, age, TC, TG, HDL, and LDL. The study was conducted under the Declaration of Helsinki and was approved by the ethics committees of each participating center. As the study was retrospective, the requirement for informed consent was waived.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Mendelian randomization study design</title>
<p>In this study, causal association analysis with outcome variables was performed by selecting Single nucleotide polymorphisms (SNPs) loci significantly associated with exposure factors as instrumental variables (IVs) and using the two-sample MR method. MR analysis needs to satisfy the following three core hypotheses: &#x2460; There was a strong correlation between IVs and exposure factors; &#x2461; IVs and any confounders associated with exposure-outcome were not relevant; &#x2462; IVs affect outcomes only through exposure factors (<xref ref-type="bibr" rid="B16">16</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Sources of GWAS summary statistics</title>
<p>Summary-level GWAS data for hypothyroidism (<xref ref-type="bibr" rid="B17">17</xref>), hyperthyroidism (<xref ref-type="bibr" rid="B17">17</xref>), type 1 diabetes (<xref ref-type="bibr" rid="B18">18</xref>), type 2 diabetes (<xref ref-type="bibr" rid="B17">17</xref>), lipid traits (HDL, LDL, and TG) (<xref ref-type="bibr" rid="B19">19</xref>), and primary frozen shoulder (<xref ref-type="bibr" rid="B20">20</xref>) were sourced from published genome-wide association studies. All GWAS datasets utilized in this study were obtained from FinnGen and the UK Biobank and are publicly accessible via the IEU Open GWAS database summary website (<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/">https://gwas.mrcieu.ac.uk/</ext-link>). Summary information on the datasets used in this study is presented in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. In addition, sex-stratified summary statistics for lipid traits and primary frozen shoulder were obtained from the UK Biobank (<ext-link ext-link-type="uri" xlink:href="https://www.nealelab.is/uk-biobank">https://www.nealelab.is/uk-biobank</ext-link>) to analyze sex-specific genetic effects.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Details of GWAS datasets used in the study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Variable</th>
<th valign="top" align="center">ID</th>
<th valign="top" align="center">Sample size</th>
<th valign="top" align="center">SNPs</th>
<th valign="top" align="center">Population</th>
<th valign="top" align="center">Year</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Hypothyroidism</td>
<td valign="top" align="center">ebi-a-GCST90018862</td>
<td valign="top" align="center">410,141</td>
<td valign="top" align="center">24,138,872</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2021</td>
</tr>
<tr>
<td valign="top" align="center">Hyperthyroidism</td>
<td valign="top" align="center">ebi-a-GCST90018860</td>
<td valign="top" align="center">460,499</td>
<td valign="top" align="center">24,289,279</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2021</td>
</tr>
<tr>
<td valign="top" align="center">Type 1 diabetes</td>
<td valign="top" align="center">ebi-a-GCST90014023</td>
<td valign="top" align="center">520,580</td>
<td valign="top" align="center">59,999,551</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2021</td>
</tr>
<tr>
<td valign="top" align="center">Type 2 diabetes</td>
<td valign="top" align="center">ebi-a-GCST90018926</td>
<td valign="top" align="center">490,089</td>
<td valign="top" align="center">24,167,560</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2021</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">ieu-b-109</td>
<td valign="top" align="center">403,943</td>
<td valign="top" align="center">12,321,875</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2020</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">ieu-b-110</td>
<td valign="top" align="center">440,546</td>
<td valign="top" align="center">12,321,875</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2020</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">ieu-b-111</td>
<td valign="top" align="center">441,016</td>
<td valign="top" align="center">12,321,875</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2020</td>
</tr>
<tr>
<td valign="top" align="center">Frozen shoulder</td>
<td valign="top" align="center">ebi-a-GCST90000512</td>
<td valign="top" align="center">451,099</td>
<td valign="top" align="center">15,184,371</td>
<td valign="top" align="center">European</td>
<td valign="top" align="center">2021</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Selection of instrumental variables</title>
<p>SNPs in exposure factors were screened by setting a genome-wide significance threshold (<italic>P&#x2009;</italic>&lt;&#x2009;5. 0&#x2009;&#xd7;&#x2009;10<sup>&#x2212;&#x2009;8</sup>). Second, independent SNPs without linkage disequilibrium (LD) were used as IVs according to the PLINK clumping algorithm (LD cut-off of r&#xb2;&lt; 0.001 within a 10 000-kilobase clumping window). The F statistic (F = beta<sup>2</sup>/se<sup>2</sup>) was used to assess the strength of genetic tools for all SNPs. We selected strong IVs with F-statistics above 10 for subsequent analysis. However, due to the large number of SNPs associated with lipid traits, we raised the F-statistic threshold to 100 to further optimize the quality of the instrumental variables and ensure the precision and robustness of the causal effect estimates. Additionally, SNPs associated with confounding factors (diabetes mellitus and thyroid dysfunction) were excluded when analyzing the causal associations between lipid traits and primary frozen shoulder.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Mendelian randomization analysis</title>
<p>In this study, inverse variance weighting (IVW) (<xref ref-type="bibr" rid="B21">21</xref>) was used as the primary method of analysis, with MR Egger (<xref ref-type="bibr" rid="B22">22</xref>), weighted median (<xref ref-type="bibr" rid="B23">23</xref>), simple mode, and weighted mode (<xref ref-type="bibr" rid="B24">24</xref>) as secondary methods of analysis.</p>
<p>Individual differences between IVs were tested using IVW and MR-Egger methods, and Cochran&#x2019;s Q statistic and p-value were used to determine the presence of heterogeneity. To determine the possibility of horizontal pleiotropy, the MR-Egger intercept method calculates the intercept term from linear regression analysis. The study&#x2019;s overall pleiotropy and horizontal pleiotropic outliers were evaluated using the MR pleiotropy residual sum and outlier (MR-PRESSO) test (<xref ref-type="bibr" rid="B25">25</xref>).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Statistical analysis</title>
<p>Statistical analysis was performed using SPSS 26.0 software. Continuous variables that satisfy normal distribution are expressed as mean &#xb1; standard deviation, and comparisons between groups are made using the independent samples t-test. Categorical variables were expressed as percentages, and comparisons between groups were made using the Chi-square test. The &#x201c;TwoSampleMR&#x201d; and &#x201c;MR-PRESSO&#x201d; packages in R (version 4.3.0) were used for MR analysis between exposures and results. The R script used in this analysis is provided in the <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. The results are expressed as odds ratio (OR) and 95% confidence interval (CI) for each standard deviation. <italic>P</italic>&#x2009;&lt;&#x2009;0.05 was considered as statistical significance.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>No difference in serum lipids between primary frozen shoulder patients and normal subjects</title>
<p>The analysis showed that after excluding patients with diabetes mellitus and thyroid dysfunction, the serum lipids (TC, TG, HDL, and LDL) in the primary frozen shoulder group were no different from those of normal individuals (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Serum lipids levels in the study and control groups.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Characteristic</th>
<th valign="top" align="center">Frozen shoulder group (n = 284)</th>
<th valign="top" align="center">Control group<break/>(n = 284)</th>
<th valign="top" align="center">t/&#x3c7;2</th>
<th valign="top" align="center">
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Male sex</td>
<td valign="top" align="center">125 (44%)</td>
<td valign="top" align="center">133(47%)</td>
<td valign="top" align="center">0.455</td>
<td valign="top" align="center">0.500</td>
</tr>
<tr>
<td valign="top" align="center">Age (years)</td>
<td valign="top" align="center">55.11 &#xb1; 5.94</td>
<td valign="top" align="center">55.25 &#xb1; 6.04</td>
<td valign="top" align="center">0.287</td>
<td valign="top" align="center">0.774</td>
</tr>
<tr>
<td valign="top" align="center">TC (mmol/L)</td>
<td valign="top" align="center">5.07 &#xb1; 0.72</td>
<td valign="top" align="center">4.99 &#xb1; 0.88</td>
<td valign="top" align="center">-1.321</td>
<td valign="top" align="center">0.187</td>
</tr>
<tr>
<td valign="top" align="center">TG (mmol/L)</td>
<td valign="top" align="center">1.19 &#xb1; 0.31</td>
<td valign="top" align="center">1.17 &#xb1; 0.32</td>
<td valign="top" align="center">-0.662</td>
<td valign="top" align="center">0.508</td>
</tr>
<tr>
<td valign="top" align="center">HDL (mmol/L)</td>
<td valign="top" align="center">1.26 &#xb1; 0.37</td>
<td valign="top" align="center">1.28 &#xb1; 0.41</td>
<td valign="top" align="center">0.627</td>
<td valign="top" align="center">0.531</td>
</tr>
<tr>
<td valign="top" align="center">LDL (mmol/L)</td>
<td valign="top" align="center">2.63 &#xb1; 0.70</td>
<td valign="top" align="center">2.54 &#xb1; 0.75</td>
<td valign="top" align="center">-1.509</td>
<td valign="top" align="center">0.132</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Effect of diabetes mellitus and thyroid dysfunction on primary frozen shoulder</title>
<p>We first evaluated the causal relationships between hypothyroidism, hyperthyroidism, type 1 diabetes mellitus, and type 2 diabetes mellitus with primary frozen shoulder by MR analysis. For subsequent analysis, 63 SNPs associated with hypothyroidism, 9 SNPs associated with hyperthyroidism, 76 SNPs associated with type 1 diabetes mellitus, and 170 SNPs associated with type 2 diabetes mellitus were identified (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;2</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>5</bold>
</xref>). The results revealed that the development of primary frozen shoulder was positively associated with hypothyroidism (OR = 1.055, 95% CI, 1.011&#x2212;1.101, <italic>P</italic> = 0.015), hyperthyroidism (OR = 1.083, 95% CI, 1.030&#x2212;1.138, <italic>P</italic> = 0.002), type 1 diabetes mellitus (OR = 1.028, 95% CI, 1.012&#x2212;1.044, <italic>P</italic> &lt; 0.001), and type 2 diabetes mellitus (OR = 1.042, 95% CI, 1.002&#x2212;1.085, <italic>P</italic> = 0.042) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). These findings provide additional evidence that hypothyroidism, hyperthyroidism, type 1 diabetes mellitus, and type 2 diabetes mellitus are independent risk factors for the development of primary frozen shoulder.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The causal effects of diabetes mellitus and thyroid dysfunction on primary frozen shoulder using two-sample Mendelian randomization methods. SNPs, single nucleotide polymorphisms; OR, odds ratios; CI, confidence interval.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1363018-g001.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Effect of serum lipids on primary frozen shoulder</title>
<p>We first evaluated whether serum lipids have a causal effect on the onset of frozen shoulder without excluding potential confounders. The results indicated a positive association between LDL and the onset of primary frozen shoulder, while HDL and TG were negatively associated with its development (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). However, significant heterogeneity and pleiotropy were observed in this analysis, which violates the core assumptions of MR analysis and indicates the influence of confounding factors (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>). In subsequent MR analyses of serum lipids and primary frozen shoulder, SNPs associated with these confounding factors will be excluded.</p>
<p>A total of 151 SNPs (HDL 58, LDL 43, and TG 50) were identified for use in MR analysis by screening the acquired SNPs according to our study design criteria (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;6</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>8</bold>
</xref>). The main MR analysis results were as follows: HDL (OR = 1.007, 95% CI, 0.931&#x2212;1.090, <italic>P</italic> = 0.857); LDL (OR = 1.000, 95% CI, 0.911&#x2212;1.098, <italic>P</italic> = 0.998); TG (OR = 0.963, 95% CI, 0.876&#x2212;1.057, <italic>P</italic> = 0.426) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). No correlation was found between serum lipids and the risk of developing primary frozen shoulder by any of the MR analysis methods in this study.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The causal effects of serum lipids on primary frozen shoulder using two-sample Mendelian randomization methods. SNPs, single nucleotide polymorphisms; OR, odds ratios; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1363018-g002.tif"/>
</fig>
<p>Given that gender is an independent risk factor for primary frozen shoulder, we also evaluated the causal relationship between serum lipids and the gender-stratified onset of primary frozen shoulder. Specifically, we identified 60 SNPs (HDL-primary frozen shoulder in females), 60 SNPs (HDL-primary frozen shoulder in males), 42 SNPs (LDL-primary frozen shoulder in females), 43 SNPs (LDL-primary frozen shoulder in males), 51 SNPs (TG-primary frozen shoulder in females), and 51 SNPs (TG-primary frozen shoulder in males) as IVs (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;9</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>14</bold>
</xref>). However, none of the MR analysis methods revealed a causal association between serum lipids and the gender-specific onset of primary frozen shoulder (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The causal effects of serum lipids on gender-stratified primary frozen shoulder using two-sample Mendelian randomization methods. SNPs, single nucleotide polymorphisms; OR, odds ratios; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1363018-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Effect of primary frozen shoulder on serum lipids</title>
<p>We then explored whether the primary frozen shoulder contributes to abnormal serum lipid levels. We adjusted the threshold to <italic>P</italic> &lt; 5. 0 &#xd7; 10<sup>&#x2212; 6</sup> screening to obtain primary frozen shoulder -associated SNPs. Based on the design criteria, 21 SNPs (primary frozen shoulder-HDL), 23 SNPs (primary frozen shoulder-LDL), and 21 SNPs (primary frozen shoulder-TG) were finally obtained as IVs for MR analysis of the effect of primary frozen shoulder on serum lipids (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;15</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>17</bold>
</xref>). The results of the IVW method of primary frozen shoulder on serum lipids were analyzed as follows: primary frozen shoulder on HDL (OR = 0.997, 95% CI, 0.983&#x2212;1.012, <italic>P</italic> = 0.711); primary frozen shoulder on LDL (OR = 0.991, 95% CI, 0.978&#x2212;1.003, <italic>P</italic> = 0.134); primary frozen shoulder on TG (OR = 0.999, 95% CI, 0.986&#x2212;1.013, <italic>P</italic> = 0.942) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). All results did not find any effect of the primary frozen shoulder on serum lipids.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The causal effects of primary frozen shoulder on serum lipids using two-sample Mendelian randomization methods. SNPs, single nucleotide polymorphisms; OR, odds ratios; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1363018-g004.tif"/>
</fig>
<p>The causal association between primary frozen shoulder and sex-stratified abnormal serum lipid levels was then analyzed in a similar manner. The IVs used for MR analysis consisted of 25 SNPs (primary frozen shoulder-HDL in females), 25 SNPs (primary frozen shoulder-HDL in males), 27 SNPs (primary frozen shoulder-LDL in females), 27 SNPs (primary frozen shoulder-LDL in males), 25 SNPs (primary frozen shoulder-TG in females), and 25 SNPs (primary frozen shoulder-TG in males) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;18</bold>
</xref>-<xref ref-type="supplementary-material" rid="SM1">
<bold>23</bold>
</xref>). Consistent with these findings, no evidence was found to support a causal association between primary frozen shoulder and sex-specific changes in serum lipid levels (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>The causal effects of primary frozen shoulder on gender-stratified serum lipids using two-sample Mendelian randomization methods. SNPs, single nucleotide polymorphisms; OR, odds ratios; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1363018-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Assessment of IVs validity and robustness in MR analysis</title>
<p>The Cochran Q test showed no intergenic heterogeneity among the IVs used for MR analysis in this study (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Moreover, neither the MR-Egger intercept test nor the MR-PRESSO global test showed signs of multidimensionality (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). The funnel plot shows that the dispersion of causal association effects is largely symmetric and the results are not potentially biased (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2</bold>
</xref>). In addition, &#x201c;leave-one-out&#x201d; sensitivity analyses showed that after eliminating each SNP in turn, the results of IVW analyses for the remaining SNPs were similar to the analyses that included all SNPs (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Heterogeneity test.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left">Exposure</th>
<th valign="top" rowspan="2" align="center">Outcome</th>
<th valign="top" colspan="3" align="center">Heterogeneity test (MR-Egger)</th>
<th valign="top" colspan="3" align="center">Heterogeneity test (IVW)</th>
</tr>
<tr>
<th valign="top" align="center">Cochran's Q</th>
<th valign="top" align="center">Q_df</th>
<th valign="top" align="center">
<italic>P</italic>
</th>
<th valign="top" align="left">Cochran's Q</th>
<th valign="top" align="center">Q_df</th>
<th valign="top" align="center">
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Hypothyroidism</td>
<td valign="top" align="center">FS</td>
<td valign="middle" align="center">77.067</td>
<td valign="middle" align="center">61</td>
<td valign="middle" align="center">0.080</td>
<td valign="middle" align="center">80.361</td>
<td valign="middle" align="center">62</td>
<td valign="middle" align="center">0.058</td>
</tr>
<tr>
<td valign="top" align="center">Hyperthyroidism</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">8.893</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">0.260</td>
<td valign="top" align="center">10.043</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">0.262</td>
</tr>
<tr>
<td valign="top" align="center">Type 1 diabetes</td>
<td valign="top" align="center">FS</td>
<td valign="middle" align="center">81.404</td>
<td valign="middle" align="center">74</td>
<td valign="middle" align="center">0.260</td>
<td valign="middle" align="center">87.440</td>
<td valign="middle" align="center">75</td>
<td valign="middle" align="center">0.154</td>
</tr>
<tr>
<td valign="top" align="center">Type 2 diabetes</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">199.712</td>
<td valign="top" align="center">168</td>
<td valign="top" align="center">0.058</td>
<td valign="top" align="center">200.303</td>
<td valign="top" align="center">169</td>
<td valign="top" align="center">0.051</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">FS</td>
<td valign="middle" align="center">56.262</td>
<td valign="middle" align="center">56</td>
<td valign="middle" align="center">0.465</td>
<td valign="middle" align="center">56.293</td>
<td valign="middle" align="center">57</td>
<td valign="middle" align="center">0.502</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">FS-females</td>
<td valign="middle" align="center">73.666</td>
<td valign="middle" align="center">58</td>
<td valign="middle" align="center">0.081</td>
<td valign="middle" align="center">74.222</td>
<td valign="middle" align="center">59</td>
<td valign="middle" align="center">0.087</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">FS-males</td>
<td valign="middle" align="center">64.084</td>
<td valign="middle" align="center">58</td>
<td valign="middle" align="center">0.272</td>
<td valign="middle" align="center">64.67491</td>
<td valign="middle" align="center">59</td>
<td valign="middle" align="center">0.285</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">FS</td>
<td valign="middle" align="center">38.404</td>
<td valign="middle" align="center">41</td>
<td valign="middle" align="center">0.587</td>
<td valign="middle" align="center">39.709</td>
<td valign="middle" align="center">42</td>
<td valign="middle" align="center">0.572</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">FS-females</td>
<td valign="middle" align="center">32.598</td>
<td valign="middle" align="center">40</td>
<td valign="middle" align="center">0.791</td>
<td valign="middle" align="center">32.598</td>
<td valign="middle" align="center">40</td>
<td valign="middle" align="center">0.791</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">FS-males</td>
<td valign="middle" align="center">34.403</td>
<td valign="middle" align="center">41</td>
<td valign="middle" align="center">0.757</td>
<td valign="middle" align="center">34.403</td>
<td valign="middle" align="center">41</td>
<td valign="middle" align="center">0.757</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">FS</td>
<td valign="middle" align="center">52.311</td>
<td valign="middle" align="center">48</td>
<td valign="middle" align="center">0.310</td>
<td valign="middle" align="center">55.373</td>
<td valign="middle" align="center">49</td>
<td valign="middle" align="center">0.247</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">FS-females</td>
<td valign="middle" align="center">46.677</td>
<td valign="middle" align="center">49</td>
<td valign="middle" align="center">0.568</td>
<td valign="middle" align="center">47.474</td>
<td valign="middle" align="center">50</td>
<td valign="middle" align="center">0.575</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">FS-males</td>
<td valign="middle" align="center">58.081</td>
<td valign="middle" align="center">49</td>
<td valign="middle" align="center">0.176</td>
<td valign="middle" align="center">59.406</td>
<td valign="middle" align="center">50</td>
<td valign="middle" align="center">0.170</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">HDL</td>
<td valign="middle" align="center">29.611</td>
<td valign="middle" align="center">19</td>
<td valign="middle" align="center">0.057</td>
<td valign="middle" align="center">30.001</td>
<td valign="middle" align="center">20</td>
<td valign="middle" align="center">0.070</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">HDL-females</td>
<td valign="middle" align="center">30.741</td>
<td valign="middle" align="center">23</td>
<td valign="middle" align="center">0.129</td>
<td valign="middle" align="center">32.165</td>
<td valign="middle" align="center">24</td>
<td valign="middle" align="center">0.123</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">HDL-males</td>
<td valign="middle" align="center">32.387</td>
<td valign="middle" align="center">23</td>
<td valign="middle" align="center">0.0925</td>
<td valign="middle" align="center">33.221</td>
<td valign="middle" align="center">24</td>
<td valign="middle" align="center">0.100</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">LDL</td>
<td valign="middle" align="center">19.120</td>
<td valign="middle" align="center">21</td>
<td valign="middle" align="center">0.577</td>
<td valign="middle" align="center">20.430</td>
<td valign="middle" align="center">22</td>
<td valign="middle" align="center">0.556</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">LDL-females</td>
<td valign="middle" align="center">25.418</td>
<td valign="middle" align="center">25</td>
<td valign="middle" align="center">0.439</td>
<td valign="middle" align="center">27.921</td>
<td valign="middle" align="center">26</td>
<td valign="middle" align="center">0.362</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">LDL-males</td>
<td valign="middle" align="center">31.225</td>
<td valign="middle" align="center">25</td>
<td valign="middle" align="center">0.182</td>
<td valign="middle" align="center">31.538</td>
<td valign="middle" align="center">26</td>
<td valign="middle" align="center">0.209</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">24.185</td>
<td valign="top" align="center">19</td>
<td valign="top" align="center">0.189</td>
<td valign="top" align="center">24.903</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center">0.205</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">TG-females</td>
<td valign="top" align="center">28.475</td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">0.198</td>
<td valign="top" align="center">32.500</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">0.115</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">TG-males</td>
<td valign="top" align="center">23.732</td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">0.419</td>
<td valign="top" align="center">25.668</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">0.370</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>FS, frozen shoulder; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Pleiotropy test.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="center">Exposure</th>
<th valign="top" rowspan="2" align="center">Outcome</th>
<th valign="top" colspan="2" align="center">Horizontal pleiotropy test<break/>(MR-Egger)</th>
<th valign="top" align="center">MR-PRESSO</th>
</tr>
<tr>
<th valign="top" align="center">Intercept</th>
<th valign="top" align="center">
<italic>P</italic>
</th>
<th valign="top" align="center">Global test <italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">Hypothyroidism</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">-0.0081</td>
<td valign="top" align="center">0.112</td>
<td valign="top" align="center">0.051</td>
</tr>
<tr>
<td valign="top" align="center">Hyperthyroidism</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">-0.0124</td>
<td valign="top" align="center">0.373</td>
<td valign="top" align="center">0.361</td>
</tr>
<tr>
<td valign="top" align="center">Type 1 diabetes</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">-0.0066</td>
<td valign="top" align="center">0.122</td>
<td valign="top" align="center">0.155</td>
</tr>
<tr>
<td valign="top" align="center">Type 2 diabetes</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">0.0022</td>
<td valign="top" align="center">0.482</td>
<td valign="top" align="center">0.050</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">0.0007</td>
<td valign="top" align="center">0.862</td>
<td valign="top" align="center">0.500</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">FS-females</td>
<td valign="top" align="center">&lt;-0.0001</td>
<td valign="top" align="center">0.511</td>
<td valign="top" align="center">0.107</td>
</tr>
<tr>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">FS-males</td>
<td valign="top" align="center">&lt;-0.0001</td>
<td valign="top" align="center">0.467</td>
<td valign="top" align="center">0.315</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">-0.0058</td>
<td valign="top" align="center">0.260</td>
<td valign="top" align="center">0.576</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">FS-females</td>
<td valign="top" align="center">&lt;-0.0001</td>
<td valign="top" align="center">0.187</td>
<td valign="top" align="center">0.757</td>
</tr>
<tr>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">FS-males</td>
<td valign="top" align="center">&lt;-0.0001</td>
<td valign="top" align="center">0.500</td>
<td valign="top" align="center">0.600</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">0.0075</td>
<td valign="top" align="center">0.100</td>
<td valign="top" align="center">0.267</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">FS-females</td>
<td valign="top" align="center">&lt;-0.0001</td>
<td valign="top" align="center">0.376</td>
<td valign="top" align="center">0.580</td>
</tr>
<tr>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">FS-males</td>
<td valign="top" align="center">&lt;-0.0001</td>
<td valign="top" align="center">0.296</td>
<td valign="top" align="center">0.209</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">HDL</td>
<td valign="top" align="center">-0.0008</td>
<td valign="top" align="center">0.622</td>
<td valign="top" align="center">0.068</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">HDL-females</td>
<td valign="top" align="center">-0.0027</td>
<td valign="top" align="center">0.313</td>
<td valign="top" align="center">0.148</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">HDL-males</td>
<td valign="top" align="center">-0.0022</td>
<td valign="top" align="center">0.450</td>
<td valign="top" align="center">0.093</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">LDL</td>
<td valign="top" align="center">0.0017</td>
<td valign="top" align="center">0.265</td>
<td valign="top" align="center">0.561</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">LDL-females</td>
<td valign="top" align="center">0.0032</td>
<td valign="top" align="center">0.129</td>
<td valign="top" align="center">0.350</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">LDL-males</td>
<td valign="top" align="center">0.0012</td>
<td valign="top" align="center">0.621</td>
<td valign="top" align="center">0.217</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">TG</td>
<td valign="top" align="center">0.0013</td>
<td valign="top" align="center">0.462</td>
<td valign="top" align="center">0.215</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">TG-females</td>
<td valign="top" align="center">0.0041</td>
<td valign="top" align="center">0.084</td>
<td valign="top" align="center">0.117</td>
</tr>
<tr>
<td valign="top" align="center">FS</td>
<td valign="top" align="center">TG-males</td>
<td valign="top" align="center">0.0032</td>
<td valign="top" align="center">0.184</td>
<td valign="top" align="center">0.389</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>FS, frozen shoulder; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Previous clinical studies have shown that dyslipidemia and primary frozen shoulder are closely related, and may be a risk factor for the development of primary frozen shoulder (<xref ref-type="bibr" rid="B9">9</xref>). In the present study, we obtained different results for the first time. After excluding patients with diabetes mellitus and thyroid dysfunction, there was no difference in serum lipid levels between the primary frozen shoulder group and the normal control group. In addition, the results of MR analyses also indicated that there was no causal relationship between dyslipidemia and primary frozen shoulder.</p>
<p>An analysis of data based on the National Health Insurance Research Database of Taiwan found that patients with hyperlipidemia had a 1.5-fold higher risk of adhesive capsulitis than did healthy controls (<xref ref-type="bibr" rid="B26">26</xref>). Several potential mechanisms may explain how blood lipids could influence primary frozen shoulder. In individuals with dyslipidemia, inflammatory factors such as interleukins and tumor necrosis factor-alpha are often elevated, which may promote the development of primary frozen shoulder through inflammatory pathways (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Additionally, alterations in lipid metabolism could affect the function of synovial tissue in the shoulder joint. Lipids influence the integrity of cell membranes and signaling pathways, including those associated with peroxisome proliferator-activated receptors and the NF-kB pathway, both of which play crucial roles in inflammation and fibrosis (<xref ref-type="bibr" rid="B29">29</xref>). Of note, the study also found that the use of statins did not prevent frozen shoulder in patients with hyperlipidemia (<xref ref-type="bibr" rid="B26">26</xref>). This result is thought-provoking. Diabetes mellitus and thyroid dysfunction are independent risk factors for the development of primary frozen shoulder (<xref ref-type="bibr" rid="B4">4</xref>). And dyslipidemia is an important component of diabetic metabolic syndrome and thyroid dysfunction (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). We therefore hypothesized that serum lipid levels in patients with primary frozen shoulder may be affected by diabetes mellitus and thyroid dysfunction. This was confirmed in the multicenter retrospective analysis conducted in this study.</p>
<p>In addition, although some single-center, small-sample studies have demonstrated a relationship between dyslipidemia and frozen shoulder. However, no study has been able to confirm whether dyslipidemia is a cause, an associated cofactor, or a consequence of primary frozen shoulder. In this study, the causal genetic link between frozen shoulder and serum lipids was examined using a two-sample MR approach based on a sizable GWAS database. To the best of our knowledge, this is the first study to use MR methods to assess the causal relationship between serum lipids and frozen shoulder. Unfortunately, the results of the MR analysis did not reveal a direct link between frozen shoulder and serum lipids.</p>
<p>The above evidence indicates that diabetes mellitus and thyroid dysfunction interfere with the relationship between dyslipidemia and the risk of developing primary frozen shoulder to the extent that the association is overestimated. This further explains why the use of statins does not protect hyperlipidemic patients from primary frozen shoulder. Although serum lipids improve with statins, diabetes mellitus and thyroid dysfunction may persist. This observation emphasizes the need for a more nuanced understanding of risk factors for primary frozen shoulder in clinical practice. For instance, clinicians should focus on managing systemic conditions like diabetes and thyroid dysfunction, which may indirectly influence the development of frozen shoulder. This shift in focus could lead to more targeted and effective preventive strategies, reducing unnecessary interventions aimed solely at lipid management in such patients. At the same time, we believe that there may be other potential factors contributing to the relationship between lipids and primary frozen shoulder that we have not yet focused on or observed. Larger genetic and intervention studies are needed to further investigate the pathophysiology of serum lipids and primary frozen shoulder.</p>
<p>The greatest strength of our study was the combination of retrospective and MR analyses, which reduced the effects of reverse causality and confounding factors. Secondly, we performed a gender-stratified MR analysis to identify gender-specific causal associations. Finally, we used multiple MR analysis methods, which increased the credibility and authenticity of our findings. In clinical settings, similar MR analyses could be applied to identify and validate causal risk factors for other musculoskeletal or metabolic disorders. This evidence-based approach could guide the development of precision medicine strategies, ensuring that interventions are directed at modifiable risk factors with proven causal links to disease outcomes.</p>
<p>Inevitably, the current study has some limitations. First, we may not be able to exclude all confounders and eliminate biased estimates of causal inference. Confounding factors such as subclinical disease states, different stages of disease progression, diet, and lifestyle may influence the relationship between serum lipids and primary frozen shoulder. Second, the GWAS dataset we use is primarily from European-origin populations. The population included in previous clinical studies and our retrospective analysis consisted of Asian individuals. The emergence of specific traits varies across racial and ethnic groups due to their different living environments and genetic backgrounds. This therefore limits the application of our findings to other populations of different races. Finally, the sample size included in this study was too small because serum lipids are not a routine examination for patients with primary frozen shoulder.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>In conclusion, retrospective observational studies and MR analyses did not reveal correlations and causal genetic relationships between serum lipids and primary frozen shoulder. These findings deepen our understanding of risk factors for primary frozen shoulder. Further studies on the pathophysiologic relationship between serum lipids and primary frozen shoulder are warranted.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Zhengzhou Central Hospital Affiliated to Zhengzhou University. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x2019; legal guardians/next of kin due to the retrospective nature of the study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>YZ: Conceptualization, Data curation, Formal analysis, Methodology, Visualization, Writing &#x2013; original draft. WF: Data curation, Writing &#x2013; original draft. YW: Data curation, Writing &#x2013; original draft. TD: Data curation, Writing &#x2013; original draft. DL: Conceptualization, Methodology, Supervision, Writing &#x2013; review &amp; editing. YS: Conceptualization, Data curation, Methodology, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Science and Technology Project of the Henan Province (grant numbers: 242102310112).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank the scholars and researchers of the UK Biobank and FinnGen studies.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1363018/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1363018/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millar</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Meakins</surname> <given-names>A</given-names>
</name>
<name>
<surname>Struyf</surname> <given-names>F</given-names>
</name>
<name>
<surname>Willmore</surname> <given-names>E</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Kirwan</surname> <given-names>PD</given-names>
</name>
<etal/>
</person-group>. <article-title>Frozen shoulder</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2022</year>) <volume>8</volume>:<fpage>59</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41572-022-00386-2</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dyer</surname> <given-names>BP</given-names>
</name>
<name>
<surname>Rathod-Mistry</surname> <given-names>T</given-names>
</name>
<name>
<surname>Burton</surname> <given-names>C</given-names>
</name>
<name>
<surname>van der Windt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bucknall</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Diabetes as a risk factor for the onset of frozen shoulder: a systematic review and meta-analysis</article-title>. <source>BMJ Open</source>. (<year>2023</year>) <volume>13</volume>:<elocation-id>e062377</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmjopen-2022-062377</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarasua</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Floyd</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bridges</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Pill</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>The epidemiology and etiology of adhesive capsulitis in the U.S. Medicare population</article-title>. <source>BMC Musculoskelet Disord</source>. (<year>2021</year>) <volume>22</volume>:<fpage>828</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12891-021-04704-9</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milgrom</surname> <given-names>C</given-names>
</name>
<name>
<surname>Novack</surname> <given-names>V</given-names>
</name>
<name>
<surname>Weil</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jaber</surname> <given-names>S</given-names>
</name>
<name>
<surname>Radeva-Petrova</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Finestone</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Risk factors for idiopathic frozen shoulder</article-title>. <source>Isr Med Assoc J</source>. (<year>2008</year>) <volume>10</volume>:<page-range>361&#x2013;4</page-range>.</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunker</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Anthony</surname> <given-names>PP</given-names>
</name>
</person-group>. <article-title>The pathology of frozen shoulder. A Dupuytren-like disease</article-title>. <source>J Bone Joint Surg Br</source>. (<year>1995</year>) <volume>77</volume>:<page-range>677&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1302/0301-620X.77B5.7559688</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunker</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Esler</surname> <given-names>CN</given-names>
</name>
</person-group>. <article-title>Frozen shoulder and lipids</article-title>. <source>J Bone Joint Surg Br</source>. (<year>1995</year>) <volume>77</volume>:<page-range>684&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1302/0301-620X.77B5.7559689</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filippatos</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tsimihodimos</surname> <given-names>V</given-names>
</name>
<name>
<surname>Pappa</surname> <given-names>E</given-names>
</name>
<name>
<surname>Elisaf</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Pathophysiology of diabetic dyslipidaemia</article-title>. <source>Curr Vasc Pharmacol</source>. (<year>2017</year>) <volume>15</volume>:<page-range>566&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1570161115666170201105425</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Menopausal impact on the association between thyroid dysfunction and lipid profiles: A cross-sectional study</article-title>. <source>Front Endocrinol (Lausanne)</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>853889</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.853889</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname> <given-names>C-M</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Park</surname> <given-names>HB</given-names>
</name>
</person-group>. <article-title>Are serum lipids involved in primary frozen shoulder? A case-control study</article-title>. <source>J Bone Joint Surg Am</source>. (<year>2014</year>) <volume>96</volume>:<page-range>1828&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2106/JBJS.M.00936</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierce</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators</article-title>. <source>Am J Epidemiol</source>. (<year>2013</year>) <volume>178</volume>:<page-range>1177&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/aje/kwt084</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cutts</surname> <given-names>S</given-names>
</name>
<name>
<surname>Massoud</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Frozen shoulder</article-title>. <source>BMJ</source>. (<year>2005</year>) <volume>331</volume>:<page-range>1453&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.331.7530.1453</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atkinson</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Eisenbarth</surname> <given-names>GS</given-names>
</name>
</person-group>. <article-title>Type 1 diabetes: new perspectives on disease pathogenesis and treatment</article-title>. <source>Lancet</source>. (<year>2001</year>) <volume>358</volume>:<page-range>221&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(01)05415-0</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatterjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Khunti</surname> <given-names>K</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Type 2 diabetes</article-title>. <source>Lancet</source>. (<year>2017</year>) <volume>389</volume>:<page-range>2239&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(17)30058-2</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Wheeler</surname> <given-names>SF</given-names>
</name>
</person-group>. <article-title>Hyperthyroidism: diagnosis and treatment</article-title>. <source>Am Fam Physician</source>. (<year>2005</year>) <volume>72</volume>:<page-range>623&#x2013;30</page-range>.</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Centanni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sachmechi</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report</article-title>. <source>J Endocrinol Invest</source>. (<year>2017</year>) <volume>40</volume>:<page-range>1289&#x2013;301</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40618-017-0706-y</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;nig</surname> <given-names>IR</given-names>
</name>
<name>
<surname>Greco</surname> <given-names>FMD</given-names>
</name>
</person-group>. <article-title>Mendelian randomization: Progressing towards understanding causality</article-title>. <source>Ann Neurol</source>. (<year>2018</year>) <volume>84</volume>:<page-range>176&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ana.25293</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaue</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kanai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tanigawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Karjalainen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kurki</surname> <given-names>M</given-names>
</name>
<name>
<surname>Koshiba</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A cross-population atlas of genetic associations for 220 human phenotypes</article-title>. <source>Nat Genet</source>. (<year>2021</year>) <volume>53</volume>:<page-range>1415&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41588-021-00931-x</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Geusz</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Okino</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Han</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>M</given-names>
</name>
<name>
<surname>Melton</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Interpreting type 1 diabetes risk with genetics and single-cell epigenomics</article-title>. <source>Nature</source>. (<year>2021</year>) <volume>594</volume>:<fpage>398</fpage>&#x2013;<lpage>402</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-021-03552-w</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname> <given-names>TG</given-names>
</name>
<name>
<surname>Sanderson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Palmer</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Ala-Korpela</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ference</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis</article-title>. <source>PloS Med</source>. (<year>2020</year>) <volume>17</volume>:<elocation-id>e1003062</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pmed.1003062</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname> <given-names>HD</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>A</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Beaumont</surname> <given-names>RN</given-names>
</name>
<name>
<surname>Tyrrell</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>A genome-wide association study identifies 5 loci associated with frozen shoulder and implicates diabetes as a causal risk factor</article-title>. <source>PloS Genet</source>. (<year>2021</year>) <volume>17</volume>:<elocation-id>e1009577</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1009577</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davey Smith</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hemani</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Mendelian randomization: genetic anchors for causal inference in epidemiological studies</article-title>. <source>Hum Mol Genet</source>. (<year>2014</year>) <volume>23</volume>:<page-range>R89&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/ddu328</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>Interpreting findings from Mendelian randomization using the MR-Egger method</article-title>. <source>Eur J Epidemiol</source>. (<year>2017</year>) <volume>32</volume>:<page-range>377&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10654-017-0255-x</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowden</surname> <given-names>J</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G</given-names>
</name>
<name>
<surname>Haycock</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator</article-title>. <source>Genet Epidemiol</source>. (<year>2016</year>) <volume>40</volume>:<page-range>304&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/gepi.2016.40.issue-4</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartwig</surname> <given-names>FP</given-names>
</name>
<name>
<surname>Davey Smith</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bowden</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption</article-title>. <source>Int J Epidemiol</source>. (<year>2017</year>) <volume>46</volume>:<page-range>1985&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ije/dyx102</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbanck</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C-Y</given-names>
</name>
<name>
<surname>Neale</surname> <given-names>B</given-names>
</name>
<name>
<surname>Do</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title>. <source>Nat Genet</source>. (<year>2018</year>) <volume>50</volume>:<page-range>693&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41588-018-0099-7</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J-Y</given-names>
</name>
<name>
<surname>Liaw</surname> <given-names>C-K</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C-C</given-names>
</name>
<name>
<surname>Liou</surname> <given-names>T-H</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>H-W</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S-W</given-names>
</name>
</person-group>. <article-title>Hyperlipidemia is a risk factor of adhesive capsulitis: real-world evidence using the Taiwanese national health insurance research database</article-title>. <source>Orthop J Sports Med</source>. (<year>2021</year>) <volume>9</volume>:<fpage>2325967120986808</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2325967120986808</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nilsson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lindholm</surname> <given-names>MW</given-names>
</name>
</person-group>. <article-title>Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages</article-title>. <source>Lipids Health Dis</source>. (<year>2006</year>) <volume>5</volume>:<fpage>17</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1476-511X-5-17</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jump</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Duke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Charalambous</surname> <given-names>CP</given-names>
</name>
</person-group>. <article-title>Frozen shoulder: A systematic review of cellular, molecular, and metabolic findings</article-title>. <source>JBJS Rev</source>. (<year>2021</year>) <volume>9</volume>:<elocation-id>e19.00153</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.2106/JBJS.RVW.19.00153</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;k&#xe9;ny</surname> <given-names>G</given-names>
</name>
<name>
<surname>Calvier</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hansmann</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>PPAR&#x3b3; and TGF&#x3b2;-major regulators of metabolism, inflammation, and fibrosis in the lungs and kidneys</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>10431</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms221910431</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>